Pharmacokinetic Study of Recombinant Monoclonal Antibody Against Human Epidermal Growth Factor Receptor Injection
Clinical trial NCT04820439 · COMPLETED
Trial details
- NCT number
- NCT04820439
- Sponsor
- The Affiliated Hospital of Qingdao University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-13
- Primary completion
- 2021-02-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.